Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Herz|March 24, 2018
[Lipid-lowering therapy in the elderly : Who profits from which target values?]E Windler, F-U Beil, G Klose, et al.International Journal of Obesity (2005)|May 3, 2006
Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162VJ Aberle, I Hopfer, F U Beil, et al.Clinical Genetics|July 6, 2005
A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term dietJ Aberle, D Evans, F U Beil, et al.Der Internist|March 3, 2004
[Primary prevention of cardiovascular diseases. Stepchild of internal medicine]E Windler, B-Chr Zyriax, F U Beil, et al.Medizinische Klinik (Munich, Germany : 1983)|June 22, 1999
[Molecular analysis of the human "growth hormone secretagogue"-receptor]S Petersenn, M Penshorn, F U Beil, et al.Current Opinion in Lipidology|December 1, 1995
Trials of the effects of drugs and hormones on lipids and lipoproteinsW A Mann, E Windler, F U Beil, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 30, 2007
Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat dietJ Aberle, I Fedderwitz, N Klages, et al.Zeitschrift Fur Naturforschung. Section C, Biosciences|March 1, 1977
Competition between oxalate and phosphate during active calcium accumulation by sarcoplasmic vesiclesF U Beil, D von Chak, W Hasselbach, et al.Atherosclerosis. Supplements|February 5, 2010
Current strategies and recent advances in the therapy of hypercholesterolemiaE Windler, B-Chr Zyriax, Chr Bamberger, et al.Clinical Endocrinology|January 29, 2000
Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomasS Petersenn, M Heyens, D K Lüdecke, et al.Pageof 12